[1]
Ferrario, L., Menzaghi, B., Rizzardini, G., Roccia, A., Garagiola, E., Bellavia, D., Schettini, F. and Foglia, E. 2025. Optimization in the HIV treatment: economic and organizational impact analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide. Global and Regional Health Technology Assessment. 12, 1 (Feb. 2025), 49–60. DOI:https://doi.org/10.33393/grhta.2025.3292.